ICTM logo
MRCCTU at UCL to present research at 10th Workshop on HIV Pediatrics and AIDS 2018

19 July 2018

This coming week features two significant events in the HIV/AIDS meeting calendar - the 10th Workshop on HIV Pediatrics, and the 22nd International AIDS Conference.

Friday marks the beginning of the 10th Workshop on HIV Pediatrics. The HIV Pediatrics Workshop is the only meeting entirely devoted to research in prevention and treatment of HIV infections in infants, children and adolescents, making it the premier forum for the world's leading researchers. The Workshop has been held annually in conjunction with the International AIDS Conference since 2009, bringing together between 200-300 global experts in pediatric, adolescent and maternal HIV research each year.

Details of the MRC CTU at UCL presentations taking place are shown below.

Session type Session Title
Oral presentation Impact of the introduction of HIV testing at birth on early infant diagnosis in KwaZulu-Natal, South Africa, 2010-2017
Poster Factors associated with poor immune reconstitution despite virologically suppressive ART in children in Europe and Thailand
Poster Safety and effectiveness of dolutegravir (DTG) in children and adolescents with HIV in the UK/Ireland.
Oral presentation Outcomes of second-line antiretroviral therapy (ART) in HIV-infected children
Oral presentation Severe immunosuppression and viral failure in adult care among antiretroviral therapy-experienced young people with HIV in the UK
Poster Mortality and AIDS-defining events among young people with HIV following transition to adult care in the UK
Poster discussion Mortality and AIDS-defining events among young people with HIV following transition to adult care in the UK
Poster Height and timing of growth spurt during puberty in children and adolescents with perinatal HIV in Europe and Thailand.
Poster Long term growth after initiation of ART in children and adolescents with perinatal HIV in Europe and Thailand.
Poster Predictors of poor immune recovery in HIV infected children receiving ART. 
Oral presentation Steady-state pharmacokinetics and early safety data in HIV-infected African children weighing ≥25kg after switching to 50mg film-coated dolutegravir tablets in the ODYSSEY trial 
Poster Steady-state pharmacokinetics and early safety data in HIV-infected African children weighing 14 to <25kg on film-coated dolutegravir 25mg tablets in the ODYSSEY trial
Poster ODYSSEY: A randomised trial evaluating the efficacy and toxicity of dolutegravir-based antiretroviral therapy compared to standard of care in HIV-infected children starting first-line or second-line therapy: design, current status and baseline characteristics
Poster “I failed to take them as I should and now I’m scared”: How can we support adolescents’ adherence on second line HIV treatment? 


Monday marks the beginning of the 22nd International AIDS Conference, in Amsterdam, the Netherlands.

The International AIDS Conference is the largest conference on any global health issue in the world. Each conference is an opportunity to strengthen policies and programmes that ensure an evidence-based response to the epidemic.

Details of the MRC CTU at UCL presentations at AIDS 2018 are shown below.

Oral abstracts

Session Title Title Authors Date Time Room
ART in infants and children Outcomes of second-line antiretroviral therapy (ART) in HIV-infected children: a CIPHER cohort collaboration global analysis Patel K, Smith C, Collins IJ, Goodall R et al  25/07/2018 14.30 - 16.00 Hall 10
Strategies for cure: Pitfalls, possibilities and promise A randomised controlled trial comparing the impact of antiretroviral therapy (ART) with a 'Kick-and-Kill' approach to ART alone on HIV reservoirs in individuals with primary HIV infection (PHI); RIVER trial Fidler S, Stohr W, Pace M, Dorrell L et al 24/07/2018 16.30 - 18.00 E102

Posters

Poster Title Authors Date Time Room
Intimate partner violence, depression, and sexual behaviour among gay, bisexual and other men who have sex with men in the PROUD trial Miltz A, Lampe F, Bacchus L, McCormack S et al 24/07/2018 12.30 - 14.30 Hall 1